Search results - 5 results
Clinical Evolution and Disease Burden in Belgian Cystic Fibrosis Patients: effect of Newborn Screening?
meconium ileus (MI), newborn screening (NBS) and clinical diagnosis (non- NBS) at 1-, 2- and 6 years of age.Methods: We conducted a retrospective observational cohort study based on data collected from the ...
Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe.
828 pwCF and SARS-CoV-2 infection. Incidence was 17.2 per 1000 pwCF (95% CI: 16.0-18.4). Median age was 24 years, 48.4% were male and 9.4% had lung transplants. SARS-CoV-2 incidence was higher in ...
Risk factors and impact of allergic bronchopulmonary aspergillosis in Pseudomonas aeruginosa-negative CF patients.
aeruginosa (Pa), were explored. METHODS: We performed a retrospective case-control study in 73 Pa-negative patients. Each patient was matched with 2 controls for age, gender, pancreas sufficiency, DeltaF508 ...
Inhaled corticosteroids and lower lung function decline in young children with cystic fibrosis.
function in Belgian CF patients. Data from patients ≥ 6 yrs of age were eligible, provided entries on lung function, height and ICS use were available in two consecutive years. Data after oral steroid use or ...
Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study.
1555 people with CF, 1452 were included in the analysis. One third were aged <18 years, and 9.4% were solid-organ transplant recipients. 74.5% were symptomatic and 22% were admitted to hospital. In ...